Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-19-023129)

Filing Details

Accession Number:: 0000899243-19-023129
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-09 16:38:08
Reporting Period:: 2019-09-05

Accepted Time:: 2019-09-09 16:38:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1341235	Aldeyra Therapeutics Inc.	ALDX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1746541	Joshua Reed	C/O Aldeyra Therapeutics, Inc. 131 Hartwell Avenue Lexington MA 02421	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-05	3,200	$4.71	35,774	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Includes 2,937 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2019.